1. Home
  2. EZPW vs NEO Comparison

EZPW vs NEO Comparison

Compare EZPW & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZCORP Inc. Non Voting

EZPW

EZCORP Inc. Non Voting

HOLD

Current Price

$32.62

Market Cap

2.0B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$16.98

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZPW
NEO
Founded
1989
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
EZPW
NEO
Price
$32.62
$16.98
Analyst Decision
Buy
Strong Buy
Analyst Count
3
8
Target Price
$30.67
$13.38
AVG Volume (30 Days)
1.0M
2.4M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
29.09
N/A
EPS
1.65
N/A
Revenue
$747,954,000.00
N/A
Revenue This Year
$25.40
$10.63
Revenue Next Year
$11.33
$9.73
P/E Ratio
$17.43
N/A
Revenue Growth
2.39
N/A
52 Week Low
$15.96
$6.38
52 Week High
$37.13
$16.92

Technical Indicators

Market Signals
Indicator
EZPW
NEO
Relative Strength Index (RSI) 61.34 64.60
Support Level $30.94 $11.49
Resistance Level $36.88 N/A
Average True Range (ATR) 1.50 0.59
MACD 0.36 -0.03
Stochastic Oscillator 89.58 95.00

Price Performance

Historical Comparison
EZPW
NEO

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buys and sells second-hand goods. The operating segments of the company are U.S. Pawn, Latin America Pawn, and Other Investments. The U.S. Pawn segment includes all pawn activities in the United States. The Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales, which are mainly collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: